Literature DB >> 17314645

Avascular necrosis rate in early reduction after failed Pavlik harness treatment of developmental dysplasia of the hip.

Hakan Senaran1, J Richard Bowen, H Theodore Harcke.   

Abstract

Our hypothesis is that hips with developmental dysplasia (DDH), which fail Pavlik harness treatment and are reduced within 3 months of age, have a low rate of avascular necrosis (AVN). Inclusion criteria are as follows: diagnosis of DDH within 2 months of birth, failure of reduction or stabilization by Pavlik harness treatment, surgical reduction of the hip advised to be performed within 3 months of age, and follow-up for Salter criteria of AVN. Twenty-one consecutive cases (35 hips) met the inclusion criteria. Nineteen cases (31 hips) were initially reduced within 3 months of age, and none of these cases developed AVN. After Pavlik harness failure, initial closed reduction was achieved in 33 (94%) of 35 hips, and open reduction required in 2 (6%) of 35 hips. At latest follow-up, one (3%) of 35 hips had AVN. At the time of reporting, 1 (3%) of the 35 hips has required an additional procedure (Pemberton osteotomy) for residual dysplasia. There were 2 outlier cases (4 hips) in which the parents delayed the reduction and 1 case developed unilateral AVN, which was reduced after the proximal femoral ossification center developed at 7 months of age. The data presented in the current study support our hypothesis.

Entities:  

Mesh:

Year:  2007        PMID: 17314645     DOI: 10.1097/01.bpb.0000248567.49089.f0

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  17 in total

1.  Idiopathic hypertonicity as a cause of stiffness after surgery for developmental dysplasia of the hip.

Authors:  Turgut Akgül; Süleyman Bora Göksan; Ilker Eren
Journal:  Int J Surg Case Rep       Date:  2014-01-27

Review 2.  Is Age or Surgical Approach Associated With Osteonecrosis in Patients With Developmental Dysplasia of the Hip? A Meta-analysis.

Authors:  Eduardo N Novais; Mary K Hill; Patrick M Carry; Patricia C Heyn
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

Review 3.  Developmental dysplasia of the hip: What has changed in the last 20 years?

Authors:  Pavel Kotlarsky; Reuben Haber; Victor Bialik; Mark Eidelman
Journal:  World J Orthop       Date:  2015-12-18

4.  Impact of Failed Pavlik Harness Treatment on the Outcomes Following Closed or Open Reduction in Developmental Dysplasia of the Hip.

Authors:  Yong Liu; Lisheng Kan; Jun Sun; Yapeng Zhang
Journal:  Indian J Orthop       Date:  2022-06-25       Impact factor: 1.033

5.  Early articular cartilage degeneration in a developmental dislocation of the hip model results from activation of β-catenin.

Authors:  Bo Ning; Jun Sun; Yi Yuan; Jie Yao; Peng Wang; Ruixue Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

6.  Operative treatment and avascular necrosis of the hip development disorder.

Authors:  Ismet Gavrankapetanović; Amel Hadžimehmedagić; Adnan Papović; Elvir Baždar
Journal:  Int Orthop       Date:  2014-05-16       Impact factor: 3.075

7.  Investigating the need for routine ultrasound screening to detect developmental dysplasia of the hip in infants born with breech presentation.

Authors:  Michelle D'Alessandro; Kimberly Dow
Journal:  Paediatr Child Health       Date:  2018-06-27       Impact factor: 2.253

8.  [Nonsurgical treatment of developmental dysplasia of the hip].

Authors:  M Nelitz; H Reichel
Journal:  Orthopade       Date:  2008-06       Impact factor: 1.004

9.  Treatment of the Developmental Dysplasia of the Hip with an Abduction Brace in Children up to 6 Months Old.

Authors:  Raphaël Wahlen; Pierre-Yves Zambelli
Journal:  Adv Orthop       Date:  2015-02-26

10.  The incidence of avascular necrosis following a cohort of treated developmental dysplasia of the hip in a single tertiary centre.

Authors:  Rahim Nawaz Hussain; Darius Rad; William John Watkins; Clare Carpenter
Journal:  J Child Orthop       Date:  2021-06-01       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.